View in EDS HTML Full Text PDF Full Text

HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.

Saved in:
Bibliographic Details
Title: HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
Authors: Brun MK; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bjørlykke KH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Viken MK; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Stenvik GE; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Klaasen RA; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Gehin JE; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Warren DJ; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Sexton J; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Sandanger Ø; Section of Dermatology, Oslo University Hospital, Oslo, Norway., Kvien TK; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Mørk C; Akershus Dermatology Center, Lørenskog, Norway., Haavardsholm EA; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Jahnsen J; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Goll GL; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Lie BA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway., Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Syversen SW; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
Source: Journal of internal medicine [J Intern Med] 2023 May; Vol. 293 (5), pp. 648-655. Date of Electronic Publication: 2023 Feb 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36843323
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brun+MK%22">Brun MK</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bjørlykke+KH%22">Bjørlykke KH</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Viken+MK%22">Viken MK</searchLink>; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Stenvik+GE%22">Stenvik GE</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Klaasen+RA%22">Klaasen RA</searchLink>; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Gehin+JE%22">Gehin JE</searchLink>; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Warren+DJ%22">Warren DJ</searchLink>; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sexton+J%22">Sexton J</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sandanger+Ø%22">Sandanger Ø</searchLink>; Section of Dermatology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kvien+TK%22">Kvien TK</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Mørk+C%22">Mørk C</searchLink>; Akershus Dermatology Center, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Haavardsholm+EA%22">Haavardsholm EA</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jahnsen+J%22">Jahnsen J</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Goll+GL%22">Goll GL</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lie+BA%22">Lie BA</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bolstad+N%22">Bolstad N</searchLink>; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jørgensen+KK%22">Jørgensen KK</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.<br /><searchLink fieldCode="AU" term="%22Syversen+SW%22">Syversen SW</searchLink>; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228904841%22">Journal of internal medicine</searchLink> [J Intern Med] 2023 May; Vol. 293 (5), pp. 648-655. <i>Date of Electronic Publication: </i>2023 Feb 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Scientific+Publications%22">Blackwell Scientific Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8904841 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2796 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209546820%22">09546820 </searchLink><i>NLM ISO Abbreviation: </i>J Intern Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36843323
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/joim.13616
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 648
    Titles:
      – TitleFull: HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brun MK
      – PersonEntity:
          Name:
            NameFull: Bjørlykke KH
      – PersonEntity:
          Name:
            NameFull: Viken MK
      – PersonEntity:
          Name:
            NameFull: Stenvik GE
      – PersonEntity:
          Name:
            NameFull: Klaasen RA
      – PersonEntity:
          Name:
            NameFull: Gehin JE
      – PersonEntity:
          Name:
            NameFull: Warren DJ
      – PersonEntity:
          Name:
            NameFull: Sexton J
      – PersonEntity:
          Name:
            NameFull: Sandanger Ø
      – PersonEntity:
          Name:
            NameFull: Kvien TK
      – PersonEntity:
          Name:
            NameFull: Mørk C
      – PersonEntity:
          Name:
            NameFull: Haavardsholm EA
      – PersonEntity:
          Name:
            NameFull: Jahnsen J
      – PersonEntity:
          Name:
            NameFull: Goll GL
      – PersonEntity:
          Name:
            NameFull: Lie BA
      – PersonEntity:
          Name:
            NameFull: Bolstad N
      – PersonEntity:
          Name:
            NameFull: Jørgensen KK
      – PersonEntity:
          Name:
            NameFull: Syversen SW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2796
          Numbering:
            – Type: volume
              Value: 293
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of internal medicine
              Type: main
ResultId 1